Amelia Deitchman, PharmD, PhD

Assistant Professor
Phone: +1 415 476-1148
2540 23rd Street, Rm 2110
UCSF Box 1221
San Francisco, CA 94110
United States

Private practice

1001 Potrero Ave
Bldg 100 Rm 157
San Francisco


What I do

My research seeks to inform novel therapeutic strategies to cure HIV through better understanding of pharmacokinetics and pharmacodynamics of individual and combinations of candidate drugs. Based out of the UCSF Drug Research Unit (DRU), I work with a multidisciplinary team of clinicians-scientists and researchers here at UCSF and across collaborative international networks on design, execution, and analysis of cure-focused clinical trials in people living with HIV. Our ultimate goal is to identify curative strategies to cure the nearly 37 million people with HIV.

Since the beginning of the COVID-19 pandemic, I’ve applied my expertise to evaluating treatments for COVID-19 and its long term sequelae, primarily through the UCSF-based Long-term Impact of Infection With Novel Coronavirus (LIINC) cohort and recently as a member of the NIH RECOVER Interventions Task Force.

Departmental research area

My research expertise

infectious disease, pharmacokinetics/pharmacodynamics, HIV cure clinical pharmacology, pharmacometric modelling and simulation, clinical translational PK/PD, COVID-19 pharmacology

Professional background

Research keywords

  • computational modeling
  • pharmacokinetics
  • Pharmacometrics
  • Protein Binding
  • HIV
  • infectious disease
  • tuberculosis
  • PK/PD
  • clinical pharmacology
  • precision medicine
  • Anti-Bacterial Agents
  • drug design
  • Critical Illness
  • pharmacokinetics
  • Anti-Infective Agents
  • Palivizumab
  • Respiratory Syncytial Virus Infections
  • Chelating Agents
  • Pharmaceutical Preparations
  • HIV-1
  • Microdialysis
  • HIV Seropositivity
  • Minocycline
  • HIV Infections